The biology of chemokines and their receptors.
By D. Rossi, A. Zlotnik. Annual Review of Immunology, 2000
2,691 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/1a40da55ee96b8d1016ed9a2e18b4522cc875266
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 (2003, background): “The chemokines CXCL9, CXCL10, and CXCL11 exhibit several activities, including the induction of proliferation of HMC (22, 23) and the inhibition of endothelial cell growth (4–10).”
- Mediators of Chronic Obstructive Pulmonary Disease (2004, background): “Over 50 different chemokines are now recognized, and they activate up to 20 different surface receptors (Rossi and Zlotnik, 2000).”
- The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. (2005, background): “Among the fi rst chemokines discovered, IL-8 was identifi ed as a chemotactic factor secreted by activated monocytes and macrophages that promotes the directional migration of neutrophils, basophils, and T lymphocytes (Baggiolini et al., 1989; Rossi and Zlotnik, 2000).”
- CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity (2001, background): “Chemokines, a class of small proteins acting via cell-surface G protein-coupled receptors, were first identified as inflammatory mediators of leukocyte chemotaxis and have been subsequently shown to possess a much larger repertoire (for review, see ref”
- Regulation of CXCR4 signaling. (2007, background): “While CXCR4 was initially cloned from leukocytes [24,25], it has since been shown to be expressed in a number of tissues in addition to cells of hematopoetic lineages [26].”
- Interconversion between two unrelated protein folds in the lymphotactin native state (2008, background): “Chemokines are small, secreted proteins that induce chemotaxis by adhering to cell-surface glycosaminoglycans on vascular endothelium and stimulating specific G protein-coupled receptors (GPCRs) expressed on target leukocytes (6).”
- Cancer and the chemokine network (2004, background): “gif" NDATA ITEM> ]> CHEMOKINES are chemotactic cytokines that cause the directed migration of leukocytes, and are induced by inflammatory cytokines, growth factors and pathogenic stimul”
- Inflammatory and immune pathways in the pathogenesis of periodontal disease (2014, background): “In addition to their cell-trafficking role, chemokines provide messages leading to other biological processes, such as angiogenesis, cell proliferation, apoptosis, tumor metastasis and host defense (48, 171, 200, 201, 267).”
- Post-translational modifications in the context of therapeutic proteins (2006, positive): “Many chemokine receptors have been shown to be tyrosine sulfated, which could render this PTM relevant to the effective functioning of processes, such as immunity, hematopoesis, angiogenesis and tumor biolog”
- Microglia as a source and target of cytokines (2002, background): “An increasing body of evidence relates to the ever growing family of chemokines (Asensio and Campbell, 1999; Mennicken et al., 1999; Rossi and Zlotnik, 2000).”
- Inflammation and cancer (2002, neutral): “A family of chemotactic cytokines, named chemokines, which possess a relatively high degree of specificity for chemoattraction of specific leukocyte population”
- Pathological and protective roles of glia in chronic pain (2009, background): “Chemokines were initially recognized as having a role in the maturation and trafficking of leukocytes during inflammatory disease”